Notice about sources This article must adhere to the biographies of living persons policy, even if it is not a biography, because it contains material about living persons. Take extra care to use high-quality sources. Material about living persons should not be added when the only sourcing is tabloid journalism; see more information on sources. Never use self-published sources about a living person unless written or published by the subject; see Wikipedia's guidelines on self-published sources and using the subject as a self-published source. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard. If you are connected to one of the subjects of this article and need help, see this page. |
You are about to undo an edit. Please check the comparison below to verify that this is what you want to do, then publish the changes below to finish undoing the edit. If you are undoing an edit that is not vandalism, explain the reason in the edit summary. Do not use the default message only. |
Latest revision | Your text | ||
Line 43: | Line 43: | ||
</ref> Frazer convinced Zhou to join him, and in 1990 they began to use [[molecular biology]] to synthesize particles [[in vitro]] that could mimic the virus. In March 1991 Zhou's wife and fellow researcher, [[Xiao-Yi Sun]],<ref name= "GGtW"> |
</ref> Frazer convinced Zhou to join him, and in 1990 they began to use [[molecular biology]] to synthesize particles [[in vitro]] that could mimic the virus. In March 1991 Zhou's wife and fellow researcher, [[Xiao-Yi Sun]],<ref name= "GGtW"> |
||
{{cite journal |last= Whittaker |first= M. |date= 4 March 2006 |title= God's Gift to Women |journal= The Weekend Australian Magazine |quote= 'Ian went to huge efforts and he got them [[Visa (document)|visas]] to Australia,' recalls [[Margaret Stanley (virologist)|Margaret Stanley]]. 'It says a lot about Ian. If anything should come over in your article, it's that Ian is an extremely kind man.'}}</ref> assembled by Zhou's instructions<ref>''Vaccines Forgotten Man'' [www.theaustralian.com.au/news/tribute-to-vaccines-forgotten-man-story-e6frg600-1111116233989]</ref> two [[L1 family|proteins]] into a [[virus-like particle|virus-like particle (VLP)]],<ref name= "RD">{{cite journal |last= Williams |first= L. |date=August 2006 |title= A Simple Idea |journal= [[Reader's Digest]] }}</ref> resembling the HPV shell, from which [[HPV vaccine]] would ultimately be made.<ref name="et" /> The vaccine completely protects [[viral infection|unexposed]] women against four HPV strains [[oncovirus|responsible for]] 70% of [[Cervix|cervical]] cancers,<ref name=ref001><!-- start of ref001 --> |
{{cite journal |last= Whittaker |first= M. |date= 4 March 2006 |title= God's Gift to Women |journal= The Weekend Australian Magazine |quote= 'Ian went to huge efforts and he got them [[Visa (document)|visas]] to Australia,' recalls [[Margaret Stanley (virologist)|Margaret Stanley]]. 'It says a lot about Ian. If anything should come over in your article, it's that Ian is an extremely kind man.'}}</ref> assembled by Zhou's instructions<ref>''Vaccines Forgotten Man'' [www.theaustralian.com.au/news/tribute-to-vaccines-forgotten-man-story-e6frg600-1111116233989]</ref> two [[L1 family|proteins]] into a [[virus-like particle|virus-like particle (VLP)]],<ref name= "RD">{{cite journal |last= Williams |first= L. |date=August 2006 |title= A Simple Idea |journal= [[Reader's Digest]] }}</ref> resembling the HPV shell, from which [[HPV vaccine]] would ultimately be made.<ref name="et" /> The vaccine completely protects [[viral infection|unexposed]] women against four HPV strains [[oncovirus|responsible for]] 70% of [[Cervix|cervical]] cancers,<ref name=ref001><!-- start of ref001 --> |
||
{{cite journal |journal= [[The New England Journal of Medicine]] |url= http://content.nejm.org/cgi/content/full/356/19/1991 |volume= 356 |issue= 19 |date= 10 May 2007 |title= HPV Vaccination – More Answers, More Questions |doi= 10.1056/NEJMe078088 |pmid= 17494932 |quote= Previous reports showed a remarkable 100% efficacy of a quadrivalent vaccine targeting HPV types 6, 11, 16, and 18 on outcomes related to vaccine HPV types in women with no evidence of previous exposure to those types [...] subgroups of subjects with no evidence of previous exposure to relevant vaccine HPV types were evaluated separately for vaccine efficacy. In these subgroups, efficacy of nearly 100% against all grades of cervical [[Cervical intraepithelial neoplasia|intraepithelial neoplasia]] and [[adenocarcinoma]] [[Carcinoma in situ|in situ]] related to vaccine HPV types was reported [...] Why is vaccine efficacy modest in the entire cohort? One factor is the apparent lack of efficacy among subjects with evidence of previous exposure to HPV types included in the vaccine. The FUTURE II trial showed no effect of vaccination |last1= Sawaya |first1= G. F. |last2= Smith-McCune |first2= Karen |pages= 1990–1991 |access-date= 30 May 2010 |archive-date= 4 January 2010 |archive-url= https://web.archive.org/web/20100104113447/http://content.nejm.org/cgi/content/full/356/19/1991 |url-status= live |
{{cite journal |journal= [[The New England Journal of Medicine]] |url= http://content.nejm.org/cgi/content/full/356/19/1991 |volume= 356 |issue= 19 |date= 10 May 2007 |title= HPV Vaccination – More Answers, More Questions |doi= 10.1056/NEJMe078088 |pmid= 17494932 |quote= Previous reports showed a remarkable 100% efficacy of a quadrivalent vaccine targeting HPV types 6, 11, 16, and 18 on outcomes related to vaccine HPV types in women with no evidence of previous exposure to those types [...] subgroups of subjects with no evidence of previous exposure to relevant vaccine HPV types were evaluated separately for vaccine efficacy. In these subgroups, efficacy of nearly 100% against all grades of cervical [[Cervical intraepithelial neoplasia|intraepithelial neoplasia]] and [[adenocarcinoma]] [[Carcinoma in situ|in situ]] related to vaccine HPV types was reported [...] Why is vaccine efficacy modest in the entire cohort? One factor is the apparent lack of efficacy among subjects with evidence of previous exposure to HPV types included in the vaccine. The FUTURE II trial showed no effect of vaccination |last1= Sawaya |first1= G. F. |last2= Smith-McCune |first2= Karen |pages= 1990–1991 |access-date= 30 May 2010 |archive-date= 4 January 2010 |archive-url= https://web.archive.org/web/20100104113447/http://content.nejm.org/cgi/content/full/356/19/1991 |url-status= live }} |
||
<!-- end of ref001 --></ref><ref name=ref002> |
<!-- end of ref001 --></ref><ref name=ref002> |
||
<!-- start of ref002 --> |
<!-- start of ref002 --> |
Copy and paste: – — ° ′ ″ ≈ ≠ ≤ ≥ ± − × ÷ ← → · § Cite your sources: <ref></ref>
{{}} {{{}}} | [] [[]] [[Category:]] #REDIRECT [[]] <s></s> <sup></sup> <sub></sub> <code></code> <pre></pre> <blockquote></blockquote> <ref></ref> <ref name="" /> {{Reflist}} <references /> <includeonly></includeonly> <noinclude></noinclude> {{DEFAULTSORT:}} <nowiki></nowiki> <!-- --> <span class="plainlinks"></span>
Symbols: ~ | ¡ ¿ † ‡ ↔ ↑ ↓ • ¶ # ∞ ‹› «» ¤ ₳ ฿ ₵ ¢ ₡ ₢ $ ₫ ₯ € ₠ ₣ ƒ ₴ ₭ ₤ ℳ ₥ ₦ № ₧ ₰ £ ៛ ₨ ₪ ৳ ₮ ₩ ¥ ♠ ♣ ♥ ♦ 𝄫 ♭ ♮ ♯ 𝄪 © ® ™
Latin: A a Á á À à  â Ä ä Ǎ ǎ Ă ă Ā ā à ã Å å Ą ą Æ æ Ǣ ǣ B b C c Ć ć Ċ ċ Ĉ ĉ Č č Ç ç D d Ď ď Đ đ Ḍ ḍ Ð ð E e É é È è Ė ė Ê ê Ë ë Ě ě Ĕ ĕ Ē ē Ẽ ẽ Ę ę Ẹ ẹ Ɛ ɛ Ǝ ǝ Ə ə F f G g Ġ ġ Ĝ ĝ Ğ ğ Ģ ģ H h Ĥ ĥ Ħ ħ Ḥ ḥ I i İ ı Í í Ì ì Î î Ï ï Ǐ ǐ Ĭ ĭ Ī ī Ĩ ĩ Į į Ị ị J j Ĵ ĵ K k Ķ ķ L l Ĺ ĺ Ŀ ŀ Ľ ľ Ļ ļ Ł ł Ḷ ḷ Ḹ ḹ M m Ṃ ṃ N n Ń ń Ň ň Ñ ñ Ņ ņ Ṇ ṇ Ŋ ŋ O o Ó ó Ò ò Ô ô Ö ö Ǒ ǒ Ŏ ŏ Ō ō Õ õ Ǫ ǫ Ọ ọ Ő ő Ø ø Œ œ Ɔ ɔ P p Q q R r Ŕ ŕ Ř ř Ŗ ŗ Ṛ ṛ Ṝ ṝ S s Ś ś Ŝ ŝ Š š Ş ş Ș ș Ṣ ṣ ß T t Ť ť Ţ ţ Ț ț Ṭ ṭ Þ þ U u Ú ú Ù ù Û û Ü ü Ǔ ǔ Ŭ ŭ Ū ū Ũ ũ Ů ů Ų ų Ụ ụ Ű ű Ǘ ǘ Ǜ ǜ Ǚ ǚ Ǖ ǖ V v W w Ŵ ŵ X x Y y Ý ý Ŷ ŷ Ÿ ÿ Ỹ ỹ Ȳ ȳ Z z Ź ź Ż ż Ž ž ß Ð ð Þ þ Ŋ ŋ Ə ə
Greek: Ά ά Έ έ Ή ή Ί ί Ό ό Ύ ύ Ώ ώ Α α Β β Γ γ Δ δ Ε ε Ζ ζ Η η Θ θ Ι ι Κ κ Λ λ Μ μ Ν ν Ξ ξ Ο ο Π π Ρ ρ Σ σ ς Τ τ Υ υ Φ φ Χ χ Ψ ψ Ω ω {{Polytonic|}}
Cyrillic: А а Б б В в Г г Ґ ґ Ѓ ѓ Д д Ђ ђ Е е Ё ё Є є Ж ж З з Ѕ ѕ И и І і Ї ї Й й Ј ј К к Ќ ќ Л л Љ љ М м Н н Њ њ О о П п Р р С с Т т Ћ ћ У у Ў ў Ф ф Х х Ц ц Ч ч Џ џ Ш ш Щ щ Ъ ъ Ы ы Ь ь Э э Ю ю Я я ́
IPA: t̪ d̪ ʈ ɖ ɟ ɡ ɢ ʡ ʔ ɸ β θ ð ʃ ʒ ɕ ʑ ʂ ʐ ç ʝ ɣ χ ʁ ħ ʕ ʜ ʢ ɦ ɱ ɳ ɲ ŋ ɴ ʋ ɹ ɻ ɰ ʙ ⱱ ʀ ɾ ɽ ɫ ɬ ɮ ɺ ɭ ʎ ʟ ɥ ʍ ɧ ʼ ɓ ɗ ʄ ɠ ʛ ʘ ǀ ǃ ǂ ǁ ɨ ʉ ɯ ɪ ʏ ʊ ø ɘ ɵ ɤ ə ɚ ɛ œ ɜ ɝ ɞ ʌ ɔ æ ɐ ɶ ɑ ɒ ʰ ʱ ʷ ʲ ˠ ˤ ⁿ ˡ ˈ ˌ ː ˑ ̪ {{IPA|}}
Wikidata entities used in this page
Pages transcluded onto the current version of this page (help):
This page is a member of 20 hidden categories (help):